Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:341-342 (9 August), doi:10.1136/bmj.327.7410.341-b
| The first 150 words of the full text of this article appear below. |
EDITORAbbasi and Smith raise major ethical issues in their editorial.1 However, the widening gap between the North and the South globally is most glaring in healthcare delivery, training, and information dissemination.
|
In already rich countries drug companies compete to spend money on doctors and other prescribers, whereas in Africa and most of Asia, doctors sweat in their attempts to get drug companies' help. In the South, where resources are meagre and inconsistent, doctors who heed Abbasi and Smith's advice do so at their peril because they may not be able to conduct research or publish papers. Poverty stricken doctors, although aware of the ethical conundrum of the handouts from drug companies, find that they cannot break the link with drug companies because to do so may mean no patient care.
The link can be broken if governments and global monetary institutions will
support doctors' research, publications, and training.
Joseph Ana, managing editor
BMJ West Africa, Luton LU2 7AE info@bmjwa.com